Key result
Electrical risk score ≥4 linked to ~5.9-fold higher in-hospital mortality in ADHF.
Why the study?
The electrical risk score (ERS) integrates multiple electrocardiographic markers of cardiac electrical instability, but its prognostic role for in-hospital and 1-year outcomes in acute decompensated heart failure (ADHF) remained unknown.
Does an admission Electrical Risk Score (ERS) ≥ 4 predict higher in-hospital and 1-year all-cause mortality compared to ERS ≤ 3 in patients hospitalized with acute decompensated heart failure?
Cohort (n=223)
All ECGs were analyzed by two independent investigators who were blinded to clinical outcomes
No
Does an admission Electrical Risk Score (ERS) ≥ 4 predict higher in-hospital and 1-year all-cause mortality compared to ERS ≤ 3 in patients hospitalized with acute decompensated heart failure?
Answers are grounded in this paper and cite their sources.
An admission Electrical Risk Score (ERS) ≥ 4 derived from routine 12-lead ECG parameters is independently associated with higher 1-year and in-hospital mortality in patients hospitalized with acute decompensated heart failure.
BACKGROUND: The electrical risk score (ERS) integrates multiple electrocardiographic markers of cardiac electrical instability. Its prognostic role in acute decompensated heart failure (ADHF) remains unknown. We evaluated the association of ERS with in-hospital and 1-year outcomes in ADHF. METHODS: In this retrospective study, 223 patients hospitalized with ADHF were included. ERS was calculated from six ECG parameters (heart rate, LV hypertrophy, QTc, Tp-e interval, QRS transition zone, frontal QRS-T angle) and dichotomized as ERS ≥ 4 (n = 98) versus ERS ≤ 3 (n = 125). The primary outcome was in-hospital mortality; secondary outcomes were 1-year mortality and HF-related rehospitalization. RESULTS: ERS ≥ 4 was associated with higher in-hospital mortality (9.2% vs. 1.6%, p = 0.009) and 1-year mortality (50.0% vs. 32.0%, p = 0.006). ERS ≥ 4 remained associated with in-hospital mortality after adjustment for sodium and GFR (OR: 5.896, 95% CI: 1.201-28.933, p = 0.029) and with 1-year mortality after adjustment for GFR, sodium, albumin, hemoglobin, and atrial fibrillation (OR: 2.153, 95% CI: 1.163-3.985, p = 0.015). ERS alone showed modest discrimination for 1-year mortality (AUC: 0.622, p = 0.002). Adding ERS improved model fit, though the discrimination gain was modest and non-significant (DeLong p = 0.484). Rehospitalization rates did not differ between groups (52.8% vs. 45.5% in ERS ≥ 4 vs. ≤ 3, p = 0.295). CONCLUSIONS: ERS is a simple ECG-based tool. ERS ≥ 4 was independently associated with 1-year mortality and, in an exploratory analysis, with in-hospital mortality, supporting its potential value as a complementary tool for early bedside risk stratification.
No takes yet. Share an insight, caveat, or question.
Babayiğit et al. (2026) conducted a cohort in Acute decompensated heart failure (ADHF) (n=223). Electrical risk score (ERS) ≥ 4 vs. Electrical risk score (ERS) ≤ 3 was evaluated on In-hospital mortality (OR 5.896, 95% CI 1.201-28.933, p=0.029). Electrical risk score ≥ 4 was independently associated with higher in-hospital mortality and 1-year mortality in ADHF.
Synapse has enriched 10 related papers. Consider them for comparative context: